Verrica Pharmaceuticals Inc

1NE

Company Profile

  • Business description

    Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

  • Contact

    44 West Gay Street
    Suite 400
    West ChesterPA19380
    USA

    T: +1 484 453-3300

    E: [email protected]

    https://www.verrica.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    71

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,828.7056.700.65%
CAC 407,726.2663.670.83%
DAX 4023,693.8920.600.09%
Dow JONES (US)44,494.94400.170.91%
FTSE 1008,753.1132.22-0.37%
HKSE24,221.41149.130.62%
NASDAQ20,202.89166.84-0.82%
Nikkei 22539,762.48223.85-0.56%
NZX 50 Index12,784.2949.760.39%
S&P 5006,198.010.000.00%
S&P/ASX 2008,597.7056.600.66%
SSE Composite Index3,454.792.95-0.09%

Market Movers